Tech Company Financing Transactions
Illumigen Biosciences Funding Round
Illumigen Biosciences, based in Seattle, secured $1.1 million in funding from Pacific Horizon Ventures.
Transaction Overview
Company Name
Announced On
3/31/2007
Transaction Type
Venture Equity
Amount
$1,100,000
Round
Undisclosed
Investors
Pacific Horizon Ventures (Donald Elmer)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
201 Elliott Ave. West 500
Seattle, WA 98119
USA
Seattle, WA 98119
USA
Phone
Website
Email Address
Overview
Illumigen has assembled a world-class team of scientists, clinicians, and business professionals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Operating Officer
Charles Magness
Chief Scientific Officer
Shawn Iadonato
VP - R & D
Christina Scherer
Browse more venture capital transactions:
Prev: 3/31/2007: Envista venture capital transaction
Next: 3/31/2007: Gaia Interactive venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs